Dynamics of Immune Escape during HIV/SIV Infection
暂无分享,去创建一个
[1] Becca Asquith,et al. Inefficient Cytotoxic T Lymphocyte–Mediated Killing of HIV-1–Infected Cells In Vivo , 2006, PLoS biology.
[2] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[3] A. Perelson. Modelling viral and immune system dynamics , 2002, Nature Reviews Immunology.
[4] Alessandro Sette,et al. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia , 2000, Nature.
[5] Sebastian Bonhoeffer,et al. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.
[6] Becca Asquith,et al. In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques , 2007, Proceedings of the National Academy of Sciences.
[7] Martin A. Nowak,et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.
[8] Mario Roederer,et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.
[9] Alan S. Perelson,et al. Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.
[10] F. A. Seiler,et al. Numerical Recipes in C: The Art of Scientific Computing , 1989 .
[11] Rustom Antia,et al. Mathematical models of cytotoxic T‐lymphocyte killing , 2007, Immunology and cell biology.
[12] R J D B,et al. Target Cell Limited and Immune Control Models of HIV Infection : A Comparison , 1998 .
[13] R. D. de Boer,et al. Understanding the Failure of CD8+ T-Cell Vaccination against Simian/Human Immunodeficiency Virus , 2007, Journal of Virology.
[14] M A Nowak,et al. Antigenic diversity thresholds and the development of AIDS. , 1991, Science.
[15] Sebastian Bonhoeffer,et al. Stochastic or deterministic: what is the effective population size of HIV-1? , 2006, Trends in microbiology.
[16] Sebastian Bonhoeffer,et al. Glancing behind virus load variation in HIV-1 infection. , 2003, Trends in microbiology.
[17] Rob J. de Boer,et al. Understanding the failure of CD8 T-cell vaccination against simian/human immunodeficiency virus , 2007 .
[18] G. Bocharov,et al. Recombination: Multiply infected spleen cells in HIV patients , 2002, Nature.
[19] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[20] R. Koup,et al. Decay Kinetics of Human Immunodeficiency Virus-Specific CD8+ T Cells in Peripheral Blood after Initiation of Highly Active Antiretroviral Therapy , 2001, Journal of Virology.
[21] Bonaventura Clotet,et al. HIV-1 Protease Catalytic Efficiency Effects Caused by Random Single Amino Acid Substitutions , 2006, Molecular biology and evolution.
[22] John Sidney,et al. Reversion of CTL escape–variant immunodeficiency viruses in vivo , 2004, Nature Medicine.
[23] Alan S. Perelson,et al. Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection , 2004, Journal of Virology.
[24] Jianhong Cao,et al. Evolution of CD8+ T Cell Immunity and Viral Escape Following Acute HIV-1 Infection1 , 2003, The Journal of Immunology.
[25] C. Fernandez,et al. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity. , 2005, Trends in microbiology.
[26] Christos J. Petropoulos,et al. Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus , 2006, The Journal of experimental medicine.
[27] William H. Press,et al. The Art of Scientific Computing Second Edition , 1998 .
[28] Bin Li,et al. Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution , 2006, Journal of Virology.
[29] M. Nowak,et al. Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy , 1999, Journal of Virology.
[30] D. Nixon,et al. Sequential Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape , 2007, PloS one.
[31] David C Montefiori,et al. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants , 2005, Nature Immunology.
[32] Katrina Walsh,et al. Rapid Viral Escape at an Immunodominant Simian-Human Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitope Exacts a Dramatic Fitness Cost , 2005, Journal of Virology.
[33] Philip J. R. Goulder,et al. Consistent Patterns in the Development and Immunodominance of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+ T-Cell Responses following Acute HIV-1 Infection , 2002, Journal of Virology.
[34] James I Mullins,et al. Waiting times for the appearance of cytotoxic T-lymphocyte escape mutants in chronic HIV-1 infection. , 2006, Virology.
[35] Roland R. Regoes,et al. Estimating the Effectiveness of Simian Immunodeficiency Virus-Specific CD8+ T Cells from the Dynamics of Viral Immune Escape , 2007, Journal of Virology.
[36] Miles P. Davenport,et al. In Vivo Fitness Costs of Different Gag CD8 T-Cell Escape Mutant Simian-Human Immunodeficiency Viruses for Macaques , 2007, Journal of Virology.
[37] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[38] Edward C. Holmes,et al. Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.
[39] S. Kent,et al. Fitness constraints on immune escape from HIV: Implications of envelope as a target for both HIV-specific T cells and antibody. , 2006, Current HIV research.
[40] Simon Wain-Hobson. Virus Dynamics: Mathematical Principles of Immunology and Virology , 2001, Nature Medicine.
[41] B. Walker,et al. Effective T-Cell Responses Select Human Immunodeficiency Virus Mutants and Slow Disease Progression , 2007, Journal of Virology.
[42] D. Gillespie. Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .
[43] Todd M. Allen,et al. Hitting HIV where it hurts: an alternative approach to HIV vaccine design. , 2006, Trends in immunology.
[44] John F. B. Mitchell,et al. Quantifying the uncertainty in forecasts of anthropogenic climate change , 2000, Nature.
[45] Qingsheng Li,et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells , 2005, Nature.
[46] Philip J. R. Goulder,et al. Compensatory Mutation Partially Restores Fitness and Delays Reversion of Escape Mutation within the Immunodominant HLA-B*5703-Restricted Gag Epitope in Chronic Human Immunodeficiency Virus Type 1 Infection , 2007, Journal of Virology.
[47] Rob J. De Boer,et al. Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection , 2006, PLoS Comput. Biol..
[48] E. Rosenberg,et al. Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection , 2001, The Journal of experimental medicine.
[49] Philip J. R. Goulder,et al. HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.
[50] Marion Cornelissen,et al. Identification of Sequential Viral Escape Mutants Associated with Altered T-Cell Responses in a Human Immunodeficiency Virus Type 1-Infected Individual , 2003, Journal of Virology.
[51] L. M. Mansky,et al. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.
[52] J. Goedert,et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.
[53] Andrew N. Phillips,et al. Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.